Prepare for the 2026 flu season: Influenza vaccination and immunisation updates for providers

Print
Last updated 20 March 2026
Prepare for the 2026 flu season: Influenza vaccination and immunisation updates for providers

Every year, general practices and dedicated vaccine providers help boost immunity and protect our local communities. Reminding your eligible patients that free flu vaccination is available can help minimise avoidable visits to the hospital.  

Following historically low vaccine uptake in recent years, reports of the highly contagious ‘super-K’ strain of influenza (flu), and the highest cases of flu deaths in the 21st century recorded in 2025, increasing vaccination uptake remains critical in 2026 to help reduce serious illness and preventable hospitalisation.

Read on for more information and resources designed to help enhance your practice’s delivery of flu vaccinations to your patients.

Join the Queensland Health Immunisation Program for a live webinar on influenza

Date: Thursday 26 March 2026

Time: 7:30 am to 8:30 am (AEST)

Location: This is an online event (Microsoft Teams)

Meeting ID: 450 654 986 051 23

Passcode: mt6MV7WU

If you are unable to attend the webinar, a recording will be made available on the Queensland Health website. Previous QHIP webinar recordings can be accessed on this page. 

See updated Queensland Health information for vaccine providers

All practices are encouraged to replace outdated information resources and to ensure practice teams are aware of the new immunisation schedules and guides. 

Information on Queensland Health’s immunisation schedules and programs that have been recently updates include:

Reimbursement forms are now live for the:

ATAGI Statement on the administration of seasonal influenza vaccines in 2026

In February 2026, Australian Technical Advisory Group on Immunisation (ATAGI) has updated their Statement on the Administration of Seasonal Influenza Vaccines. 

Key changes for 2026 as outlined in the ATAGI statement: 

  • Intranasally administered live attenuated influenza vaccine (LAIV; FluMist®) is available for the first time in Australia for children aged 2 to17 years. It is available by private prescription and through individual state-based vaccination programs in Queensland. 

  • LAIV is contraindicated for those with moderate or severe immunocompromise. More information on LAIV is provided in the Australian Immunisation Handbook Influenza chapter. 

  • When receiving influenza vaccine for the first time, healthy children aged 6 months to <2 years and those with a medical risk condition aged 6 months to <9 years with a medical risk condition should receive 2 doses, given 4 weeks apart.  

  • The registration age for adjuvanted influenza vaccine (Fluad®) has been extended to people aged 50 years and above. Fluad is NIP funded for people aged 65 years and above. People 50 to 64 years of age can access this through the private market.  

  • All influenza vaccines available in Australia in 2026 are trivalent (i.e. containing two A strains and one B lineage). The B Yamagata lineage virus is no longer included in influenza vaccines as it may be extinct. 

More resources and support